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1. Acute Respiratory Failure in a 33-year-old Man with Granulomatous Lung Disease 
Participants: 
Protoco l : Dr. George C. Bower, Department of Internal Med ic ine , Div is ion of Pulmonary Med ic ine 
Discussant: Dr. W i l l i a m Conway, Department o f Internal Med ic ine , Div is ion of Pulmonary Med ic ine 
Radiology: Dr. Michae l Engel, Department of Diagnostic Radiology 
Pathology: Dr. Julius M . Ohorodn i k , Department of Pathology 
Case Presentation 
A 33-year-old black man was transferred to Henry Ford Hospital in 
August, 1975 from another hospital where he had been for ten days 
with a diagnosis of possible tuberculosis. Three weeks earlier, he 
had begun to cough and produce dark green sputum that was 
occasionally blood tinged. He denied chest pain, fever, chills, 
sweating, weight loss, or anorexia. He had not iced some 
breathlessness during the preceding year but this was not aggra-
vated during the recent illness. He had not worked for a number of 
years, smoked one pack of cigarettesdaily, and drankone six-pack 
of beer daily. There was no history of TB exposure, but he stated that 
he had had penumonia three times in the past, the last time in 
October, 1974. He took phenytoin and phenobarbital for a seizure 
disorder. 
On examination he did not appear ill. Blood pressure was 130/80, 
pulse was regular at 72 / min, and his respirations were normal. A 
1.5 cm nodule was noted in the left parotid area. The chest 
exhibited good expansion. Diminished breath sounds and in-
creased fremitus were noted in the area ofthe right middle lobe. A 
few rales were heard at both bases. The rest of the exam ination was 
unremarkable. 
Laboratory examinations included a hemoglobin of 14.7cm, white 
blood cell count 4,500 with a normal differential, and normal 
platelet and reticulocyte counts. Urinalysis was normal, creatinine 
1.0 mg/d l , calcium 9.2 mg/d l , and phosphate 4.4 mg/d l . LDH, 
SCOT, and bilirubin were normal. Alkaline phosphatase was 64 
onits (normal 9-38). Serum albumin was 3.4 and globulin 3.9 
gm/d l . Protein electrophoresis yielded normal values for globulin 
fractions. Urinary calcium was 121 mg/24 hours. Numerous 
sputum studies were negative for acid-fast bacilli on smear and 
culture. No pathogenic fungi were cultured. Complement fixation 
tests for histoplasmosis, blastomycosis, and coccidioidomycosis 
were negative. PPD-T, SKSD, monilia, histoplasmin, and coc-
cidioidin skin tests were negative. 
A chest radiograph showed a diffuse infiltrative process in both 
lungs, most pronounced in the right upper lobe, and consolida-
tion in the middle lobe and in partof the right lower lobe. There was 
a suggestion of an enlarged azygos node and the left hilum 
appeared generous. Laminograms revealed the middle lobe bron-
chus to be patent but narrowed. Liver/spleen scan showed 
homogenous uptake in the liver without hepatosplenomegaly. 
Spleen size appeared normal. 
Bronchoscopy revealed a friable, diffuse cobblestone and granular 
appearance of the mucosa, with increased secretions. The right 
middle lobe bronchus was narrowed by a heaped-up process. 
Biopsies revealed noncaseating granulomatous inftammation con-
sistent with sarcoidosis. Pulmonary function studies showed a 
forced vital capacity of 2.41 (predicted 5.43). FEV .^o was 1.32 I 
(predicted 4.55). Maximum voluntary ventilation was 48 L/min 
(predicted 186). Following a bronchodilator, the FVC was 3.08, 
FEV,.o was 1.43, and M W was 54. Residual lung volume was 3.0 I 
(predicted 1.92), total lung capacity 5.41 (predicted 7.47), and 
diffusing capacity 21.7 (predicted 37). Seven-minute nitrogen 
washout yielded a value of 4.2%. Resting arterial blood gases 
showed a PO2 of 57 mm Hg, saturation 91%, PC02 26 mm Hg, 
pH 7.43. A-a gradient for oxygen was 50 mm Hg. During exercise, 
oxygen consumption was 1.58 1 /min , respiratory quotient 0.93, 
and ventilatory equivalent for oxygen was 33. V Q / V J rose from 
0.41 at rest to 0.52 during exercise and the A a-gradient rose to 59. 
The P02 during exercise was 43, saturation 74%, PC02 42, and 
pH 7.32. The shunt fraction was calculated at 18.7%. 
The patient was treated for one week with Keflex for presumptive 
infective bronchitis. No ocular lesions of sarcoidosis were found. 
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Sputum cytology was reported suspicious for malignant cells, but 
repeat studies were negative. He was discharged on prednisone 80 
mgq.o.d., isoniazid, pyridoxine, phenytoin, and phenobarbital. 
The patient did not return for any clinic appointments. His final 
hospital admission was six months later on February 14, 1976 
when he came to the Emergency Room complaining of wheezing 
and marked increase in shortness of breath for one week. Sputum 
had increase in amount and was described as red for one week. He 
denied fever and chills, had not been taking medications, and had 
continued to smoke and drink heavily. He was in acute respiratory 
distress, was noted to have an injected pharynx, poor teeth, one 
small left axillary lymph node, diffuse rales throughout his chest, 
and scattered wheezes. Cardiac examination was unremarkable, 
blood pressure was 110/60, pulse 112, respirations 32 /min , and 
temperature 37°C. The remainder of the examination was also 
unremarkable. Hemoglobin on admission was 14.8, white blood 
cell count 28,200, and electrolytes, BUN, and creatinine were 
normal. An arterial blood study with the patient receiving2 l /min 
of oxygen by nasal specs showed a P02 of 33 mm Hg, saturation 
61%, PC02 28 mm Hg, and pH 7.35. With a 60% rebreathing 
mask, P02 was 73, saturation 94%, PC02 was 29, and pH 7.36. 
The patient was transferred to the medical intensive care unit. 
Sputum showed numerous gram-posi t ive cocc i in pairs and 
chains, some gram-negative bacilli, and a few large gram-positive 
cocci and tetrads. Sputum smears were negative for AFB. Chest x-
ray showed marked reticular and nodular changes, espcially in the 
upper lung fields, normal heart size, possible right hilar enlarge-
ment, and some clearing of the right middle lobe infiltrate. 
Follow-up film showed increased perihilar infiltrates. He was 
treated with oxygen and was afebrile but continued to have 
tachycardia and a paradoxical pulse of about 26. P02s remained 
in the range of 50 to 60 mm Hg on high concentrations of oxygen, 
and PC02s ranged from 20 to 30 mm Hg. Electrocardiogram 
showed an incomplete right bundle branch block. Large doses of 
Solumedrol were administered along with IV aminophylline and 
IPPB with bronchodilators. By February 16 the respiratory rate was 
40 /min , blood pressure 100/70, and heart rate 130/min. He 
appeared tired and in considerable distress. Sputum cultures were 
reported as showing rare staph aureus, numerous Neisseria, 
micrococci, and rare Hemophilus inftuenzae. Cephazolin was 
begun. An S3 gallop was heard. He was started on digoxin and 
furosemide and a Swan-Canz catheter was inserted; right artrial 
pressure was 12/4, right ventricle 76 /0 , pulmonary artery 76/12, 
and wedge pressure 11 mm Hg. Shortly thereafter, he became 
bradycardic and unresponsive. Resuscitation was instituted, and 
he vomited and aspirated. He was intubated, placed on a respirator 
and developed atrial flutter with a 2 to 1 block. Despite the use o fa 
transthoracic pacemaker, blood pressure could not be obtained 
and the patient died. 
Clinical Discussion 
Dr. Conway: 
This young black man with a history of alcohol abuse, 
cigarette smoking, and seizure disorder was inftially hospi-
talized and found to have a diffuse granular bronchitis. 
pulmonary infiltrates, and a combined obstructive and 
restrictive lung disease wfth hypoxemia. He was treated for 
sarcoidosis but was unreliable in follow-up. Five months 
later he presented to the hospital wfth diffuse pulmonary 
infiltrates and died. 
The first procedure in any patient with a suspected diagnosis 
of sarcoidosis should be to verify the diagnosis, since a large 
number of diseases can mimic sarcoidosis histologically. 
Three criteria should be fulfil led: first, the histology should 
be compatible; second, theclinical presentation and course 
should be compatible; and finally, other causes of gran-
ulomatous disease should be excluded. This patient had 
compatible histology which was obtained from a bronchial 
and transbronchial biopsy, but before commenting on his 
clinical presentation, we should review the x-rays. 
Dr. Engel: 
The initial x-ray in August, 1975 (Figure 1) shows a some-
what hazy appearance inthe perihilar regions wfth densfties 
extending into the periphery. An infiltrate is present in the 
middle lobe, resulting in the so-called silhouette sign. There 
is a diffuse, somewhat linear to nodular pattern throughout 
both lungs wfth more patchy densities in the right upper 
lobe. Laminograms do not demonstrate definite adenopathy 
though there is suggestive fullness inthe perftracheal region. 
The intermediate bronchus is narrowed and the middle lobe 
is reduced in size. At the time of the final admission in 
February, 1976 (Figure2), bilateral infiltrates are presentwith 
patchy densities in the right upper lobe, more striking than 
on the original films. The lower lung fields are relatively 
clear. Just before the patient died, the pulmonary infiltrates 
progressed to a picture resembl ing the pattern of pulmonary 
edema but the heart was not enlarged (Figure 3). 
Dr. Conway: 
The bilateral reticulo-nodular characteristics ofthe infiltrate 
are consistent wfth sarcoidosis and are best classified as 
stage 3 disease. The atypical features include atelectasis and 
infiltration in the right middle lobe. When this occurs in 
sarcoidosis it is almost always due to extensive endo-
bronchial disease with bronchial obstruction. Another 
atypical feature is the relative lack of symmetry in the 
parenchymal infiltrates, which can occur in around 5-13% 
ofcases, especially when the disease is evolving or regress-
ing. When asymmetry occurs in the upper lobes, it suggests 
the possibility of tuberculosis. Despite these features, the x-
rays are still compatible with sarcoidosis. 
The clinical presentation was also compatible wfth sar-
coidosis. The patient was young; 70% of individuals wfth 
sarcoid are under 40. He was black, and the disease is more 
common in blacks. Also, anergy was present, which occurs 
in a high percentage of patients wfth the disease. The 
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Fig.1 Fig. 3 
Fig. 2 
Strongest clinical support for a diagnosis of sarcoidosis over 
other causes of diffuse pulmonary infiltrates is the presence 
of multiorgan involvement. Although there is no clearcut 
evidence of other organ involvement in this patient, I think 
we can accept as supporting evidence the elevated alkaline 
phosphatase and the presence o fa parotid nodule. Parotid 
gland involvement occurs in 5% of patients with sar-
coidosis.^ However, the key factor in my decision that this 
patient had sarcoidosis was the bronchoscopic finding. A 
diffuse cobblestone appearance with friable mucosa and 
extensive involvement of the right middle lobe bronchus 
were described. Diffuse granular bronchftis is nearly pa-
thonomonic of endobronchia l involvement w i th sar-
coidosis. Moreover, the diseases commonly considered in 
the differential diagnosis do not generally produce these 
endobronchial changes. Finally, there is little evidence to 
support the presence of other common disorders which 
cause granulomatous inflammation. Berylliosis is just about 
indistinguishable from sarcoidosis and generally requires a 
history of exposure to make a diagnosis. Manifestations of 
sarcoidosis that have not been described in berylliosis are 
uveftis, erythema nodosum, and parotftis. Berylliosis can be 
caused by exposure to rocket fuel and to exotic alloys used 
in the aerospace industry. Since, to my knowledge, Michi-
gan has no such industry, this is unlikely. Hypersensitivity 
pneumonia, another possibility, would also require some 
further environmental history but should not cause the 
airway changes that occurred in this patient. The possibility 
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of a fungal or tuberculous infection was excluded by the 
number of specimens sent. If the endobronchial changes 
were misinterpreted and were, in fact, caused by an infec-
tious agent, the cultures certainly should have been positive, 
as they are in a high percentage of patients with endo-
bronchial tuberculosis. Cancer and lymphoma are some-
times considered in the differential diagnosis of sarcoidosis 
when hilar and paratracheal adenopathy are present, but 
these findings were not definite in this patient, ft is impor-
tant to differentiate carcinoma from sarcoid when the 
histologic studies are obtained from a node that could 
possibly be draining a site of cancer. Since the biopsy here 
was obtained directly from bronchial and lung tissue, there 
should not be much reason to confuse it with a car-
cinomatous process. 
The pulmonary function studies showed a moderate restric-
tive defect with severe airflow obstruction. Most published 
reports of lung function in sarcoidosis have stressed the 
occurrence of a restrictive defect. Recently, attention has 
been drawn to three types of airway disease. The first is 
small ainA'ays dysfunction, which can even occur in patients 
who have only bilateral hilar lymph adenopathy, i.e., stage 1 
disease.^ Secondly, airway disease occurs in the terminal 
fibrotic stage of sarcoidosis. In a recent report of 16 patients 
with extensive fibrosis due to sarcoidosis and little or no 
smoking history, 75% had mild to severe airflow obstruc-
tion.^ The changes were attributed to the narrowing and 
distortion of the airways caused by bronchial and per-
ibronchial fibrosis. Manifestations of this type of involve-
ment include cough, sputum product ion, wheez ing, 
recurrent pneumonia, and atelectasis. Finally, a i r f low 
obstruction can occur in the presence of endobronchial 
infiltration by sarcoid granulomas. This is the type of 
involvement I believe our patient had. Because endo-
bronchial involvement can occur in any stage ofthe disease, 
it has been suggested that bronchoscopy be performed and 
steroid therapy instftuted in patients with stage 1 disease 
who have airway symptoms." Our own experience is that 
about halfthe patients with stage 1 disease have histologic 
evidence of endobronchial disease. 
At this point, we should ask what the natural course of 
disease could be in this patient. The prognosis in any case is 
unpredictable but, in general, two thirds recover completely 
with minimal residual lesions. Indications for a good prog-
nosis include an acute onset, the presence of hilar adenopa-
thy alone, onset w i th erythema nodosum, and an 
asymptomatic state. Poor prognostic signs include insidious 
onset with pulmonary parenchymal involvement, cut-
aneous or bone involvement, or involvement of more than 
three organ systems. In terms of the radiographic stages of 
the disease, individuals with stage 1 disease alone stand a 
greater chance for recovery than those with stage 3 disease 
(parenchymal involvement alone).' Thus, this case clearly 
had a poor prognosis. 
Finally, was sarcoidosis the only cause of death? Only 
5% of patients with sarcoidosis eventually die ofthe disease, 
usually 3 to 20 years after diagnosis.' The most common 
cause of death is respiratory failure due to progressive and 
severe fibrosis. Although this patient did have evidence of 
respiratory failure, the radiographic picture is not that of 
end-stage fibrosis. Cor pulmonale may cause death, but ft 
usually occurs after a decade of disease and is associated 
with severe fibrosis. It is generally fatal within a year after the 
first episode of heart failure. However, this patient had no 
radiographic or electrocardiographic evidence of cor pul-
monale, and the d isease was not present for the usual length 
of time required forthis complication. Hemorrhage dueto 
bronchiectasis or a fungus ball is also an occasional cause of 
death, but the severity of hemoptysis in this case was not 
sufficient to cause death. Unusual causes of death include 
renal failure due to hypercalcemia, hepatic failure due to 
granulomatous hepatitis, and myocardial involvement. 
While autopsy evidence of card iac involvement is present in 
20%, the importance ofthis finding has been stressed only 
recently. Manifestations are arrhythmia, most commonly 
ventricular, heart block which is frequently manifested by 
syncope or sudden death, congestive heart failure due to 
extensive myocardial infiltration, and, much less often, 
papillary muscle dysfunction. The presence of myocardial 
involvement is felt to be incidental in one third of autopsy 
cases and is felt to be a significant abnormality or direct 
cause of death in about two thirds.'^ In one autopsy series of 
cardiac sarcoidosis, 75% of the patients who died, died 
suddenly,^ and the remainder were related to progressive 
heart failure. Others have shown that in myocardial sar-
coidosis all sudden deaths were preceded by a cardiac 
rhythm disturbance. In fact, the presence of arrhythmias 
was felt to be the most predictive factor for determining 
whether myocardial sarcoidosis was present. Ninety per-
centof the sudden death victims in Roberts' series' had some 
prior manifestations of cardiac sarcoidosis, usually an ar-
rhythmia or the presence of heart block. Although in-
complete bundle branch block was described in our patient, 
I don't think there was significant cardiac involvement. 
The most common nonsarcoid causes of death are infec-
tions, such as tuberculosisor bacterial pneumonia. The final 
illness in our patient was manifested by increased secre-
t ions, wheezing, dyspnea, and hemoptysis. There was 
marked leukocytosis, severe hypoxemia with a large shunt, 
and increase in the pulmonary infiltrates developing over a 
short period of time. Sarcoidosis does not typically produce 
such an acute deterioration, and 1 believe that there must 
have been a superimposed process such as bacterial pneu-
monia. The large terminal paradoxical pulse was probably a 
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manifestation of severe airflow obstruction. Certainly, there 
was no indication of cardiac enlargement or pericardial 
effusion. The hemodynamic data suggest that pulmonary 
hypertension was present, probably on the basis of hypoxia 
combined with parenchymal lung disease ratherthan direct 
pulmonary vascular involvement with sarcoid granulomas. 
What could have been the immediate cause of death in this 
patient? The development of an arrhythmia or heart block 
should have been picked up in the intensive care unit, and I 
doubt that this was present. A major vessel rupture is 
unlikely in this young patient. Pulmonary embolism should 
be considered but discarded because of his age, ambulatory 
state until two days before admission, and absenceof heart 
failure. Mural thrombi have been reported in sarcoidosis but 
usually require extensive myocardial involvement which is 
not 1 ikely in this case. The term inal event seems to have been 
the development of progressive hypoxemia. I believe we 
wi l l find extensive sarcoidosis involving the pulmonary 
parenchyma, bronchi, hilar lymph nodes, and possibly the 
pulmonary vasculature and liver. I suspect the presence of 
bacterial pneumonia as well. 
Pathology Discussion 
Dr. Ohorodnik: 
At autopsy the lungs were twice their normal weight, 
diffusely fibrotic, and contained fresh emboli in the second-
ary branches of the arteries in both lower lobes and with 
early hemorrhagic infarction. The heart was slightly en-
larged and the right side dilated. The superior vena cava 
near its entrance into the right atrium was thickened and 
involved by an inflammatory process. A review of the 
transbronchial biopsy done during life confirms the pres-
ence of noncaseating granulomas consisting of histiocytes 
and multinucleated giant cells wfth no necrosis (Figure 4). 
In some areas of the lung, extensive parenchymal alteration 
occurred. Considerable scarring and contraction was pre-
sent, some of which extended to the pleural surface. Many 
of the granulomas were confluent. In the early or active 
stage one can see the lymphocytes at the periphery of the 
lesions, but in older lesions more fibrosis occurs and 
remnants of the granulomas are not specific. Microscopic 
examination of the smaller airways showed, in some, a 
Fig. 4 
Transbronchial biopsy. Noncaseating granuloma. 
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Fig. 5 
Longitudinal section of bronchiole. Intraluminal polypoid granulomas. 
polypoid appearance due to infiltration of their walls by 
granulomas (Figure 5). The alveolar walls contained gran-
ulomas in some areas and in others a simple interstitial 
inflammatory reaction which can be seen in sarcoidosis 
without the distinctive granulomas. Some of the pulmonary 
veins were involved by a granulomatous angiitis. The lesion 
in the superior vena cava was involved microscopically by 
the same sort of granulomatous disease (Figures 6 and 7). 
Some of the intrathoracic lymph nodes were scarred and 
fibrotic, and in others typical sarcoid granulomas were 
present. A few intracytoplasmic asteroid bodies were noted, 
but although these are sometimes described as characteris-
tic of sarcoidosis, I do not believe they are specific. Cho-
lesterol crystals were noted in the cytoplasm of some ofthe 
giant cells. The liver was minimally involved but did contain 
a few poorly formed granulomas. The granulomas in this 
particular case showed no evidence of organisms on special 
stains or culture. 
It is important to emphasize that the histologic process we 
have looked at can sometimes be due to specific diseases 
such as tuberculosis or histoplasmosis. A recent article in 
Cancer* described eight patients receiving adjuvant ther-
apy with BCG, all of whom had osteogenic sarcoma and 
developed diffuse nodules in the lungs. Histologically, these 
were granulomas indistinguishable from sarcoidosis. The 
point I want to make is that the diagnosis of sarcoidosis 
should not be made merely on the basisof compatible tissue 
morphology and requires supporting clinical correlation. 
There was no evidence of cardiac or central nervous system 
involvement by sarcoidosis in our patient. The problem here 
was essentially limited to the lungs. 
Questions 
Was the lesion in the superior vena cava due to sarcoidosis? 
Dr. Ohorodnik: 
The lesion in the superior vena cava could be described as 
sarcoid angiitis. Angiitis was present in the pulmonary veins 
but not in vessels ofother organs. A recent report indicated 
that in one series 69% of open lung biopsies in patients with 
sarcoidosis showed involvement of the vessels.^  Perhaps 
we are not looking closely enough for this type of involve-
ment. I doubt that the pulmonary emboli in this case 
originated in the pulmonary vessels. They most likely came 
from the lower extremities. 
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Fig. 6 
Superior vena cava. Normal wall to the left. Center and right markedly thickened by granulomatous inflammation. 
Was there evidence of pneumonia? 
Dr. Ohorodnik: 
There was nothing to suggest true bacterial pneumonia, but 
you must appreciate that these lungs were badly damaged. 
Was there any evidence of splenic involvement in this case? 
Dr. Ohorodnik: 
The spleen was not involved by sarcoidosis. There was some 
evidence of extramedullary hematopoesis. The bone mar-
row was likewise uninvolved. 
Dr. Rebuck: 
I would like to ask the clinicians if patients with known 
Boeck's sarcoidosis are still remarkable by their lack of 
intercurrent clinical infections. Many years ago Dr. Rich-
mond Smith and V° reported a very peculiar inversion ofthe 
normal leukocytic responses in the skin windows of a 
patient wfth sarcoid. Normally, neutrophils and monocytes 
respond early to antigenic stimulation to be followed by the 
lymphocytes and macrophages. In our report the mac-
rophages predominated in the sarcoid patient in the early 
hours of inflammation. We suggested at the time that such an 
overt macrophage defense should protect patients wfth 
sarcoid from the customary day-to-day intercurrent infec-
tions, and such seemed to be the d i n ical experience in those 
years. This characteristic, but not diagnostic, finding in 
sarcoidosis has been used as a confirmatory test, ft has been 
confirmed in the European literature," and more recently by 
the McMasters University group in Hamilton, Ontario. The 
overt response of macrophages means that these patients are 
not ordinarily infected by bacterial organisms susceptible to 
macrophage destruction, only by those organisms such as 
tubercle bacilli which are handled poorly by macrophages. 
Dr. Bower: 
It is uncommon to see patients dying with sarcoidosis, which 
makes this particular case more interesting. I have not been 
impressed that our sarcoidosis patients have an unusual 
numberof infectionsof any type. Tuberculosis, at least inthe 
past, was commonly implicated as a final illness but this 
certainly does not seem to be the case at the present time. 
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Fig. 7 
Superior vena cava, subintimal. Granulomatous angiitis. 
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